RBC Capital analyst Rishi Jaluria lowered the firm’s price target on Salesforce to $200 from $235 but keeps an Outperform rating on the shares. The company’s Q3 results disappointed relative to a "low bar", while deteriorating macro conditions are driving a Q4 cRPO growth guide of just 7%, which is below both sell-side and buy-side expectations, the analyst tells investors in a research note. Salesforce continues to compound cRPO growth in the teens and there are many avenues to sustain growth however, including monetizing organic innovation on the core front-office clouds as well as accelerating the growth of acquired assets through cross-sell and bundling, Jaluria adds.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CRM:
- 5 Great Stocks to Gift Yourself This Holiday Season
- Big Moves in the Cloud: Quarterly Results Spur Bullish Software Sentiment
- Salesforce Stock (NYSE:CRM): Beware of the Silent Enemy, Stock-Based Compensation
- Salesforce price target lowered to $180 from $215 at Canaccord
- Salesforce price target lowered to $210 from $240 at Truist